GSEA was conducted and revealed that the low SARDH expression in HCC was linked to various critical signaling pathways, including Fceri Mediated MAPK activation, WNT Signaling pathway, Fceri mediated NF Kb activation, as well as PI3k- FGFR1 cascade. The gene discussed is SARDH; the disease is hepatocellular carcinoma.